Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#370 of 589

William Plovanic

Canaccord Genuity · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Nov 2025

Analyst rating accuracy & track record

William Plovanic is an equity research analyst at Canaccord Genuity. Quantellect has scored 37 of their stock calls across 10 companies. Their picks beat their sector 38% of the time over the next 12 months, and their price targets were reached 48% of the time within a year.

Win % vs sector
38%
PT Hit % (12mo)
48%
Avg sector-excess
−8.3%
Scored calls
37
Tickers
10
Tier
Provisional

Track record

Quantellect has scored 37 of William Plovanic's stock calls across 10 companies, dating back to 2021. Their rated stocks beat their own sector 38% of the time over the next 12 months. On a typical call, a Plovanic pick returned −8.3% more than its sector over the following year.

Of the scored calls, 37 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
HTFLHeartflow, Inc. Common Stock
Buy$40.00Nov 2025+47.8%Hit
CVRXCVRx Inc
Buy$11.00Nov 2025−118.6%Miss
IRTCiRhythm Technologies Inc
Buy$212.00Oct 2025−60.7%Miss
TMDXTransMedics Group Inc
Buy$147.00Oct 2025−79.1%Hit
ATRCAtriCure Inc
Buy$64.00Oct 2025+48.0%Miss
TMDXTransMedics Group Inc
Buy$142.00Oct 2025−56.0%Hit
ANGOAngioDynamics Inc
Buy$18.00Oct 2025+20.9%Miss
HTFLHeartflow, Inc. Common Stock
Buy$39.00Sep 2025+14.8%Hit
HTFLHeartflow, Inc. Common Stock
Buy$35.00Sep 2025+31.9%Hit
STIMNeuronetics Inc
Buy$7.00Aug 2025−72.9%Miss
GMEDGlobus Medical
Buy$90.00Jul 2025+21.2%Hit
ANGOAngioDynamics Inc
Buy$17.00Jul 2025+38.3%Miss
TMDXTransMedics Group Inc
Buy$142.00Jul 2025−52.9%Hit
CVRXCVRx Inc
Buy$18.00Apr 2025−2.1%Miss
ATRCAtriCure Inc
Buy$52.00Mar 2025−12.7%Miss
STIMNeuronetics Inc
Buy$8.00Mar 2025−76.5%Miss
CBLLCeriBell, Inc
Buy$33.00Feb 2025−27.2%Miss
ATRCAtriCure Inc
Buy$66.00Feb 2025−31.1%Miss
CVRXCVRx Inc
Buy$23.00Feb 2025−62.0%Miss
CVRXCVRx Inc
Buy$22.00Dec 2024−44.1%Miss
CBLLCeriBell, Inc
Buy$33.00Dec 2024−34.3%Miss
CBLLCeriBell, Inc
Buy$31.00Nov 2024−62.2%Hit
BVSBioventus Inc
Buy$15.00Nov 2024−33.1%Miss
CBLLCeriBell, Inc
Buy$30.00Nov 2024−57.7%Hit
CVRXCVRx Inc
Buy$17.00Oct 2024−18.9%Hit
Prev1
Go to

William Plovanic: analyst track record FAQ

Is William Plovanic a good stock analyst?

Yes, by track record. William Plovanic ranks number 370 of 589 of the analysts Quantellect scores, with an Analyst Score of 25 out of 100. Past results do not guarantee future ones.

What is William Plovanic's win rate?

William Plovanic's win rate is 38%. Across 37 scored calls, their rated stocks beat their sector 38% of the time over the next 12 months. On a typical call they returned −8.3% more than the sector.

What stocks and sectors does William Plovanic cover?

William Plovanic covers 10 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are William Plovanic's price targets accurate?

William Plovanic's price targets are reached within 12 months 48% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow William Plovanic's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does William Plovanic rank among Wall Street analysts?

William Plovanic ranks number 370 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.